Life Sciences Commercialization Strategy
The Spencer Fane Britt & Browne LLP Life Sciences Practice assists multinational
corporations, private research institutes, university systems, trade associations,
patient advocacy and disease organizations, start-up companies, and individual
entrepreneurs in coordinating the legal, business and scientific aspects of
the commercialization process. Our attorneys and consultants focus on the core
areas at the intersection of law, business and science encountered by most clients
in commercializing a life sciences technology:
The Life Sciences Practice focuses on the legal aspects of the commercialization
process in a manner that is informed by the business of bringing biotechnologies,
pharmaceuticals, medical devices and therapies to market. We integrate these
traditionally stand-alone legal and business practices into a multi-disciplinary,
multi-office practice. Unlike the traditional model in which a client is required
to seek a different group of business consultants or attorneys to implement
each of the core steps of biocommercialization (i.e., "pushing" the
technology through the process), the Life Sciences Practice provides these capabilities
in one organization to assist innovators in "pulling" their technologies through
the process using an integrated market-focused strategy.
Our attorneys and scientific advisors have decades of experience not only in
the law, but in industry and academic research as well. As a multi-practice
law firm, our Life Sciences attorneys work seamlessly with other Spencer Fane
practice groups including international,
financial
services, litigation,
antitrust
and unfair competition, real
estate, non-competes
and trade secrets, labor,
employee
benefits, bankruptcy
and environmental.